tiprankstipranks
Advertisement
Advertisement

JP:4565 Stock Latest News

Nxera Pharma Refreshes Board While Maintaining Core Leadership Team
Company AnnouncementsNxera Pharma Refreshes Board While Maintaining Core Leadership Team
5d ago
Nxera Pharma Secures $3 Million Milestone Payment from Centessa
PremiumCompany Announcements
Nxera Pharma Secures $3 Million Milestone Payment from Centessa
25d ago
Nxera Pharma Files for South Korean Approval of Insomnia Drug Daridorexant
PremiumCompany Announcements
Nxera Pharma Files for South Korean Approval of Insomnia Drug Daridorexant
26d ago
Sosei Group Earnings Call Marks Cautious Transition
PremiumCompany Announcements
Sosei Group Earnings Call Marks Cautious Transition
1M ago
Nxera Pharma Revamps Board to Strengthen Governance and Growth Strategy
PremiumCompany Announcements
Nxera Pharma Revamps Board to Strengthen Governance and Growth Strategy
1M ago
Nxera Pharma tightens focus as Japan and APAC portfolio powers 2025 growth
PremiumCompany AnnouncementsNxera Pharma tightens focus as Japan and APAC portfolio powers 2025 growth
2M ago
Nxera Pharma Slashes Executive Bonuses Following 2025 Results
Premium
Company Announcements
Nxera Pharma Slashes Executive Bonuses Following 2025 Results
2M ago
Nxera Pharma boosts Japan-APAC portfolio and pipeline as 2025 restructuring sharpens growth focus
Premium
Company Announcements
Nxera Pharma boosts Japan-APAC portfolio and pipeline as 2025 restructuring sharpens growth focus
2M ago
Nxera Pharma Slashes Executive Bonuses After FY2025 Results to Sharpen Capital Discipline
PremiumCompany Announcements
Nxera Pharma Slashes Executive Bonuses After FY2025 Results to Sharpen Capital Discipline
2M ago
Nxera Pharma Grows Revenue but Widens Loss on R&D and Finance Costs in 2025
PremiumCompany Announcements
Nxera Pharma Grows Revenue but Widens Loss on R&D and Finance Costs in 2025
2M ago
Nxera Pharma books ¥24.3bn non-cash impairment with no impact on consolidated results
PremiumCompany Announcements
Nxera Pharma books ¥24.3bn non-cash impairment with no impact on consolidated results
2M ago
Nxera Pharma Swings to Deeper FY2025 Loss but Guides for Strong Profit Rebound in 2026
PremiumCompany Announcements
Nxera Pharma Swings to Deeper FY2025 Loss but Guides for Strong Profit Rebound in 2026
2M ago
Nxera Pharma to Book $1.8 Million Milestone from Centessa Collaboration
PremiumCompany AnnouncementsNxera Pharma to Book $1.8 Million Milestone from Centessa Collaboration
2M ago
Nxera Pharma spins out GPCR program to new life sciences-backed company
Premium
Company Announcements
Nxera Pharma spins out GPCR program to new life sciences-backed company
2M ago
Nxera Pharma’s Insomnia Drug Daridorexant Clears Key Phase 3 Hurdle in South Korea
Premium
Company Announcements
Nxera Pharma’s Insomnia Drug Daridorexant Clears Key Phase 3 Hurdle in South Korea
2M ago
Nxera Pharma Secures US$3.6 Million Milestone from Centessa Collaboration
PremiumCompany Announcements
Nxera Pharma Secures US$3.6 Million Milestone from Centessa Collaboration
3M ago
Nxera Pharma Secures Asia-Pacific Rights to Santhera’s Vamorolone for Duchenne Muscular Dystrophy
PremiumCompany Announcements
Nxera Pharma Secures Asia-Pacific Rights to Santhera’s Vamorolone for Duchenne Muscular Dystrophy
3M ago
Nxera Pharma Completes ¥5 Billion Buyback of 2028 Convertible Bonds
PremiumCompany Announcements
Nxera Pharma Completes ¥5 Billion Buyback of 2028 Convertible Bonds
3M ago
Nxera Pharma Regains Full Rights to Phase 2–Ready Schizophrenia Drug After Boehringer Ingelheim Opts Out
PremiumCompany Announcements
Nxera Pharma Regains Full Rights to Phase 2–Ready Schizophrenia Drug After Boehringer Ingelheim Opts Out
3M ago
Nxera Completes Buyback and Consent Solicitation for Convertible Bonds
PremiumCompany AnnouncementsNxera Completes Buyback and Consent Solicitation for Convertible Bonds
4M ago
Nxera Pharma Receives Dividends from UK Subsidiary
Premium
Company Announcements
Nxera Pharma Receives Dividends from UK Subsidiary
4M ago
Nxera Pharma Initiates Bond Buyback and Consent Solicitation
Premium
Company Announcements
Nxera Pharma Initiates Bond Buyback and Consent Solicitation
4M ago

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >